IAM Issue 38

The UK’s IP minister outlines his
policy priorities and examines some
of the issues facing patent owners
in Europe and further afield

Executing more effective patenting
requires senior managers to create
a winning patenting culture, apply
levers to prevent default patenting
and enable people to meet the
additional requirements

If patent owners want to generate
maximum returns from the
monetisation of their rights, they
need to look beyond well-worn
money-making strategies

It is only a matter of time before the
integration of IP and product
development becomes part of the
mainstream business process.
Companies have to decide whether
they want to be leaders or laggards
as this happens

There has never been a better
opportunity for IP executives to claim
their rightful place as leaders of
corporate growth and value creation

Consumers are ready to start
spending again. Companies that
can learn the lessons taught by the
masters of intangible asset
management will be the first
to benefit

Dawn raids marked the start of a
European Commission inquiry that
focused on the pharmaceutical
sector’s use of patents. However,
the final report from the inquiry
team did not herald the crackdown
many had feared

Businesses adept at generating
inventions from R&D frequently fail to
recognise outside patent opportunities.
Who or what is to blame?

EPO President Alison Brimelow was
seeking clarity when she asked the
office’s Enlarged Board of Appeal to
consider the patentability of computer
programs in Europe. Unfortunately, she
may not get what she is after

IP valuations have sunk to record lows,
but we’re now poised to see things
swing in a new direction

This issue's featured industry data includes key patent ketrics for companies in the Health Care Industry.

NPEs – or patent trolls – are
far from the evil they are often
said to be. But that will not
stop some operating
companies from waging war
on them, as well as the law
firms and funds with which
they work

Speaking up for IP: greater coordination and greater focus on societal benefits needed

Driving collaboration across the
intellectual property lifecycle maximises
return on your IP investments, writes
Adam Kenney of Thomson Reuters